Green Fresh Biotechnology Company Limited (Green Fresh Bio) filed its Monthly Return for Equity Issuer for the period ended 31 July 2026, indicating no changes to either authorised or issued share capital.

• Authorised capital remained at 50.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 500.00 million.

• Issued share count was unchanged at 874.12 million ordinary shares. The company held no treasury shares, leaving total issued shares likewise at 874.12 million.

• Green Fresh Bio confirmed its public float exceeds the Main Board’s Initial Prescribed Threshold of 25 percent of issued shares, satisfying Hong Kong Listing Rule 13.32D(1).

• The filing reports no share options, warrants, convertible securities, or other equity‐linked instruments outstanding or exercised during the month, and no share repurchases or cancellations.

• All requisite regulatory confirmations were provided by the company secretary on 03 August 2026, affirming compliance with Hong Kong listing requirements and relevant corporate and statutory obligations.